UnitedHealth Group Inc (UNH)

Won't touch this group, including Humana, which is in a massive reset.

The stock has been flat, but at current share prices he's been adding. UNH is the giant of US healthcare. Now is a great entry point. Trades at 18x PE. Can deliver 8-10% topline growth and around 8-9% bottom line. They have a great track record. They participate in Medicare Advantage with a 20% market share.

Owns shares in company. Usually weakness in shares before US election with worries of healthcare changes. Would recommend holding. 

The health sector is poised to rally after a rough year. UNH is a good company though he prefers Humana.

His largest position. A quality, defensive names that benefits from employment growth. Also, what will the weight-loss drug do for them? Smart managers. A permanent compounder.

Rallied 5% in Q3. Had come back after Covid and good for them, but he prefers Humana (he owns).

Likes the diversified business model. Leader. Decent valuation at 19x forward PE, with 12% earnings growth. Past year has seen a rotation out of managed care into more exciting pharma names. Stable revenues, downturn-resilient. Aging US demographics will benefit.

Very well manged company - best in sector.
Does not own shares.
Investing in other areas in healthcare sector.
Share price falling on concerns for pricing power.
Good long term investment. 

Likes their fundamentals as well as the healthcare sector, a sector which has been rallying.

Likes it, with the economy opening up and the company securing some price increases. Not a home run stock. You're looking at returns of 10-15% per annum.

He owns many healthcare names including UHN, but isn't excited about these names because they have lost momentum. Their CFO has warned of higher costs, which has lowered the bar a today. Earnings beat today, yes, but the bar is very low.

A core holding. It performed well, though down 8% this year. Revenue is up 13%, though costs up 16%. Their medical ratio is at 83% vs. 81% last year, but in line with the street. Shares are jumping today on earnings.

Shares are down 9% YTD, but is rallying 8% today on strong earnings. Has always liked this stalwart in healthcare.

Massive insurance company with very strong business.
Mostly benefiting from secular growth.
16% compounding rate in earnings. 
Current share price presenting great opportunity to buy.
Excellent long term hold.